Coya Therapeutics Inc. (NASDAQ: COYA) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT COYA THERAPEUTICS INC.

Coya Therapeutics Inc. (NASDAQ: COYA)
Listen to this Section


$6.30
-0.0590 ( +0.18% ) 26.8K

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Market Data


Open $6.30
Previous Close $6.36
Volume 26.8K
Market Cap $108.10M
Day Range $6.30 - $6.51
52 Week Range $4.75 - $10.69
Shares Outstanding 16.71M
Change % +0.18%
Net Change ▼ -0.0590
Insider Ownership -0.02%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
IPO Year 2022
Country United States
Under Writer Chardan Capital Markets, Newbridge Securities, Joseph Gunnar, more

Insider Ownership Transactions

Total Amount Purchased: -687,663.00

Date Type Amount Purchased Purchaser
2024-11-14 Buy 1800.00 SNYDER DAVID S
2024-11-13 Buy 5000.00 Swaminathan Arun
2024-11-12 Buy 2710.00 Grossman Fred
2024-11-12 Buy 5000.00 Swaminathan Arun
2024-06-05 Sale -70596.00 Grossman Fred
2024-06-05 Sale -163663.00 Berman Howard
2024-06-05 Sale -70596.00 SNYDER DAVID S
2024-03-05 Buy 1000.00 Lee Ann
2024-02-02 Sale -189680.00 Berman Howard
2024-02-02 Sale -81819.00 SNYDER DAVID S

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 05, 2024
8-k 8K-related 14 Jun 05, 2024
8-k 8K-related 15 May 20, 2024
10-q Quarterly Reports 51 May 09, 2024
8-k 8K-related 12 May 09, 2024
8-k 8K-related 14 May 08, 2024
defa14a Other 3 Mar 29, 2024
def Proxies and info statements 2 Mar 28, 2024
defa14a Other 3 Mar 28, 2024
ars Annual reports 1 Mar 28, 2024

Latest News


× Before browsing our site, please accept our cookies policy